Structure of the leukemia oncogene LMO2: Implications for the assembly of a hematopoietic transcription factor complex

Blood

Volumn 117, Issue 7, 2011, Pages 2146-2156

  El Omari, Kamel ^a   Hoosdally, Sarah J ^b   Tuladhar, Kapil ^b   Karia, Dimple ^a   Vyas, Paresh ^b   Patient, Roger ^b   Porcher, Catherine ^b   Mancini, Erika J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIM ONLY PROTEIN 2; NUCLEIC ACID BINDING PROTEIN; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; DNA BINDING; DNA PROTEIN COMPLEX; EMBRYO; GENE STRUCTURE; HEMATOPOIESIS; HUMAN; IN VITRO STUDY; LEUKEMIA; MOLECULAR DOCKING; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

EID: 79951831250     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-07-293357     Document Type: Article

References (60)

1. Boehm T, Foroni L, Kaneko Y, Perutz MF, Rabbitts TH. The rhombotin family of cysteinerich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc Natl Acad Sci U S A. 1991;88(10):4367-4371. (Pubitemid 21914541)
2. Royer-Pokora B, Loos U, Ludwig WD. TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene. 1991;6(10):1887-1893. (Pubitemid 21924023)
3. Van Vlierberghe P, van Grotel M, Beverloo HB, et al. The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia. Blood. 2006;108(10):3520-3529.
4. McCormack MP, Young LF, Vasudevan S, et al. The Lmo2 oncogene initiates leukemia in mice by inducing thymocyte self-renewal. Science. 2010;327(5967):879-883.
5. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003;302(5644):415-419. (Pubitemid 37296260)
6. Kadrmas JL, Beckerle MC. The LIM domain: from the cytoskeleton to the nucleus. Nat Rev Mol Cell Biol. 2004;5(11):920-931. (Pubitemid 39486543)
7. Begley CG, Green AR. The SCL gene: from case report to critical hematopoietic regulator. Blood. 1999;93(9):2760-2770. (Pubitemid 29200765)
8. Larson RC, Lavenir I, Larson TA, et al. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J. 1996;15(5):1021-1027. (Pubitemid 26077830)
9. Valge-Archer VE, Osada H, Warren AJ, et al. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc Natl Acad Sci U S A. 1994;91(18):8617-8621.
10. Porcher C, Swat W, Rockwell K, Fujiwara Y, Alt FW, Orkin SH. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell. 1996;86(1):47-57. (Pubitemid 26256577)
11. Shivdasani RA, Mayer EL, Orkin SH. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL. Nature. 1995;373(6513):432- 434.
12. Patterson LJ, Gering M, Eckfeldt CE, et al. The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish. Blood. 2007;109(6):2389-2398. (Pubitemid 46425879)
13. Osada H, Grutz GG, Axelson H, Forster A, Rabbitts TH. LIM-only protein Lmo2 forms a protein complex with erythroid transcription factor GATA-1. Leukemia. 1997;11(suppl 3):307-312.
14. Begay-Muller V, Ansieau S, Leutz A. The LIM domain protein Lmo2 binds to AF6, a translocation partner of the MLL oncogene. FEBS Lett. 2002;521(1):36-38. (Pubitemid 34628453)
15. Jurata LW, Kenny DA, Gill GN. Nuclear LIM interactor, a rhombotin and LIM homeodomain interacting protein, is expressed early in neuronal development. Proc Natl Acad Sci U S A. 1996;93(21):11693-11698. (Pubitemid 26347184)
16. Agulnick AD, Taira M, Breen JJ, Tanaka T, Dawid IB, Westphal H. Interactions of the LIM-domain-binding factor Ldb1 with LIM homeodomain proteins. Nature. 1996;384(6606):270-272. (Pubitemid 26396977)
17. Wadman I, Li J, Bash RO, et al. Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia. EMBO J. 1994;13(20):4831-4839. (Pubitemid 24319365)
18. Wadman IA, Osada H, Grutz GG, et al. The LIMonly protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J. 1997;16(11):3145-3157. (Pubitemid 27234954)
19. Jurata LW, Gill GN. Functional analysis of the nuclear LIM domain interactor NLI. Mol Cell Biol. 1997;17(10):5688-5698. (Pubitemid 27411076)
20. Bach I. The LIM domain: regulation by association. Mech Dev. 2000;91(1):5-17. (Pubitemid 30125900)
21. Grutz G, Forster A, Rabbitts TH. Identification of the LMO4 gene encoding an interaction partner of the LIM-binding protein LDB1/NLI1: a candidate for displacement by LMO proteins in T cell acute leukaemia. Oncogene. 1998;17(21):2799-2803. (Pubitemid 28554239)
22. Warren AJ, Colledge WH, Carlton MB, Evans MJ, Smith AJ, Rabbitts TH. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell. 1994;78(1):45-57. (Pubitemid 24228299)
23. Yamada Y, Warren AJ, Dobson C, Forster A, Pannell R, Rabbitts TH. The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. Proc Natl Acad Sci U S A. 1998;95(7):3890-3895. (Pubitemid 28173224)
24. Vyas P, McDevitt MA, Cantor AB, Katz SG, Fujiwara Y, Orkin SH. Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene. Development. 1999;126(12):2799-2811. (Pubitemid 29338639)
25. Vitelli L, Condorelli G, Lulli V, et al. A pentamer transcriptional complex including tal-1 and retinoblastoma protein downmodulates c-kit expression in normal erythroblasts. Mol Cell Biol. 2000;20(14):5330-5342. (Pubitemid 30431586)
26. Anderson KP, Crable SC, Lingrel JB. Multiple proteins binding to a GATA-E box-GATA motif regulate the erythroid Kruppel-like factor (EKLF) gene. J Biol Chem. 1998;273(23):14347-14354. (Pubitemid 28319151)
27. Grutz GG, Bucher K, Lavenir I, Larson T, Larson R, Rabbitts TH. The oncogenic T cell LIM-protein Lmo2 forms part of a DNA-binding complex specifically in immature T cells. EMBO J. 1998;17(16):4594-4605. (Pubitemid 28377160)
28. Yamada Y, Pannell R, Forster A, Rabbitts TH. The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. Proc Natl Acad Sci U S A. 2000;97(1):320-324. (Pubitemid 30055829)
29. Yamada Y, Pannell R, Forster A, Rabbitts TH. The LIM-domain protein Lmo2 is a key regulator of tumour angiogenesis: a new anti-angiogenesis drug target. Oncogene. 2002;21(9):1309-1315. (Pubitemid 34214496)
30. Ma S, Guan XY, Beh PS, et al. The significance of LMO2 expression in the progression of prostate cancer. J Pathol. 2007;211(3):278-285. (Pubitemid 46172703)
31. Deane JE, Mackay JP, Kwan AH, Sum EY, Visvader JE, Matthews JM. Structural basis for the recognition of ldb1 by the N-terminal LIM domains of LMO2 and LMO4. EMBO J. 2003;22(9):2224-2233. (Pubitemid 36565545)
32. Terano T, Zhong Y, Toyokuni S, Hiai H, Yamada Y. Transcriptional control of fetal liver hematopoiesis: dominant negative effect of the overexpression of the LIM domain mutants of LMO2. Exp Hematol. 2005;33(6):641-651. (Pubitemid 40725830)
33. Deane JE, Sum E, Mackay JP, Lindeman GJ, Visvader JE, Matthews JM. Design, production and characterization of FLIN2 and FLIN4: the engineering of intramolecular ldb1:LMO complexes. Protein Eng. 2001;14(7):493-499. (Pubitemid 32846935)
34. Ryan DP, Sunde M, Kwan AH, et al. Identification of the key LMO2-binding determinants on Ldb1. J Mol Biol. 2006;359(1):66-75.
35. El Omari K, Porcher C, Mancini EJ. Purification, crystallization and preliminary X-ray analysis of a fusion of the LIM domains of LMO2 and the LID domain of Ldb1. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010;66(11):1466-1469.
36. Otwinowski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1996;276:307-326.
37. Adams PD, Grosse-Kunstleve RW, Hung LW, et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr Sect D Biol Crystallogr. 2002;58(11):1948-1954. (Pubitemid 35337293)
38. Vagin A, Teplyakov A. MOLREP: an automated program for molecular replacement. J Appl Cryst. 1997;(30):1022-1025. (Pubitemid 127485985)
39. Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr Sect D Biol Crystallogr. 2004;60(12):2126-2132. (Pubitemid 41742764)
40. BUSTER-TNT 2.5.1 and autoBUSTER 1.3.1 [computer program]. Cambridge, United Kingdom: Global Phasing; 2008.
41. Davis IW, Leaver-Fay A, Chen VB, et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 2007;35(Web Server issue):W375-W383.
42. de Vries SJ, van Dijk AD, Bonvin AM. WHISCY: what information does surface conservation yield? Application to data-driven docking. Proteins. 2006;63(3):479-489.
43. Emekli U, Schneidman-Duhovny D, Wolfson HJ, Nussinov R, Haliloglu T. HingeProt: automated prediction of hinges in protein structures. Proteins. 2008;70(4):1219-1227. (Pubitemid 351304082)
44. Krissinel E, Henrick K. Inference of macromolecular assemblies from crystalline state. J Mol Biol. 2007;372(3):774-797. (Pubitemid 47321791)
45. DeLano WL. The PyMOL Molecular Graphics System [computer program]. San Carlos, CA, 2002.
46. Porcher C, Liao EC, Fujiwara Y, Zon LI, Orkin SH. Specification of hematopoietic and vascular development by the bHLH transcription factor SCL without direct DNA binding. Development. 1999;126(20):4603-4615.
47. Schuh AH, Tipping AJ, Clark AJ, et al. ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis. Mol Cell Biol. 2005;25(23):10235-10250. (Pubitemid 41681951)
48. Westerfield M. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Brachydanio rerio). Eugene, OR: University of Oregon Press; 1993.
49. Gering M, Yamada Y, Rabbitts TH, Patient RK. Lmo2 and Scl/Tal1 convert non-axial mesoderm into haemangioblasts which differentiate into endothelial cells in the absence of Gata1. Development. 2003;130(25):6187-6199. (Pubitemid 38008818)
50. Jowett T, Yan YL. Double fluorescent in situ hybridization to zebrafish embryos. Trends Genet. 1996;12(10):387-389. (Pubitemid 26336473)
51. Bhati M, Lee C, Nancarrow AL, et al. Implementing the LIM code: the structural basis for cell type-specific assembly of LIM-homeodomain complexes. EMBO J. 2008;27(14):2018-2029.
52. Deane JE, Ryan DP, Sunde M, et al. Tandem LIM domains provide synergistic binding in the LMO4: Ldb1 complex. EMBO J. 2004;23(18):3589-3598. (Pubitemid 39336281)
53. Lecuyer E, Lariviere S, Sincennes MC, et al. Protein stability and transcription factor complex assembly determined by the SCL-LMO2 interaction. J Biol Chem. 2007;282(46):33649-33658. (Pubitemid 350159506)
54. Schmeichel KL, Beckerle MC. Molecular dissection of a LIM domain. Mol Biol Cell. 1997;8(2):219-230. (Pubitemid 27097939)
55. Flores SC, Lu LJ, Yang J, Carriero N, Gerstein MB. Hinge Atlas: relating protein sequence to sites of structural flexibility. BMC Bioinformatics. 2007;8:167.
56. Schlaeger TM, Schuh A, Flitter S, et al. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1. Mol Cell Biol. 2004;24(17):7491-7502. (Pubitemid 39121477)
57. Osada H, Grutz G, Axelson H, Forster A, Rabbitts TH. Association of erythroid transcription factors: complexes involving the LIM protein RBTN2 and the zinc-finger protein GATA1. Proc Natl Acad Sci U S A. 1995;92(21):9585-9589.
58. Liew CK, Simpson RJ, Kwan AH, et al. Zinc fingers as protein recognition motifs: structural basis for the GATA-1/friend of GATA interaction. Proc Natl Acad Sci U S A. 2005;102(3):583-588. (Pubitemid 40282708)
59. Appert A, Nam CH, Lobato N, et al. Targeting LMO2 with a peptide aptamer establishes a necessary function in overt T-cell neoplasia. Cancer Res. 2009;69(11):4784-4790.
60. Matthews JM, Bhati M, Craig VJ, et al. Competition between LIM-binding domains. Biochem Soc Trans. 2008;36(6):1393-1397.